Article
Identification and Analysis of Molecular Pathways and Key Candidate Biomarkers in Glioblastoma Multiforme
2022-10-04
Abstract excerpt
Glioblastoma Multiforme (GBM) is a Grade IV malignant primary tumor present in the central nervous system. Despite advancements in treatments, it has a poor prognosis as the median survival is 14-15 months. The goal of this study was to identify the candidate biomarkers as well as the functional pathways regulated in GBM. The dataset (GSE100675) accessed included 3 glioblastoma tissues, 3 paired tissues, and 3 nor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 37e12b5c-85b6-5919-a2e3-0e95171c0b67
- DOI
- 10.21203/rs.3.rs-2127048/v1
